On Tuesday, Evofem Biosciences Inc. (OTCQB: EVFM) came into focus after further information emerged with regards to the company’s potential acquisition by Aditxt Inc. Evofem Biosciences Files Preliminary Proxy for Stockholder Approval of the Acquisition by Aditxt Aditxt runs an innovative platform focused on speeding up high-potential healthcare innovations, and yesterday it announced that Evofem …
EVFM
Evofem Biosciences Inc. (NASDAQ:EVFM) Stock Attempts To Bounce From Lows: But Why?
Evofem Biosciences Inc. (NASDAQ:EVFM) was up 5% after the company announced the successful extension of the cumulative net sales covenant timing of the April 2020 Securities Purchase and Securities Agreement to June 30, 2023. Market Stats On Monday, EVFM stock jumped 4.61% at $0.4812 with more than 5.99 million shares, compared to its average volume …
Evofem Biosciences (NASDAQ:EVFM) Stock Continues to Fall: Down 18% In A Week
Evofem Biosciences (NASDAQ:EVFM) has dropped 18% in a week. Recently the company priced the previously publicized underwritten public offering of 50 million common shares plus warrants to acquire up to 50 million common shares. The company sells each share accompanied by a short-term warrant to buy one Evofem common share at $1 per common share …
Continue reading “Evofem Biosciences (NASDAQ:EVFM) Stock Continues to Fall: Down 18% In A Week”